74. Asymmetric C–H functionalization of cyclopropanes using an isoleucine-NH2 bidentate
directing group
Kim, J.; Sim, M.; Kim, N.; Hong, S.
Chem. Sci. 2015, 6, 3611. (Highlighted in Literature Coverage in Synform: 2015, 10, A136-A139)
72. Rh(III) and Ru(II)-Catalyzed Site-Selective C–H Alkynylation of Quinolones
Kang, D.; Hong, S.
Org. Lett. 2015, 17, 1938.
71. Rh(I)-Catalyzed Site-Selective Decarbonylative Alkenylation and Arylation of Quinolones under Chelation Assistance
Kwon, S.; Kang, D.; Hong, S.
Eur. J. Org. Chem. 2015, 17, 3615. (Highlighted as a Front Cover)
70. Rh(III)-Catalyzed Direct C–H/C–H Cross-Coupling of Quinones with Arenes Assisted by Directing Group: Identification of Carbazole Quinones as GSKb Inhibitors
Moon, Y.; Jeong, Y.; Kook, D.; Hong, S.
Org. Biomol. Chem. 2015, 13, 3918.
69. Efficient Synthesis of Frutinone A and Its Derivatives via Palladium-Catalyzed C-H Activation/Carbonylation
Shin, Y.; Yoo, C.; Moon, Y.; Lee, Y.; Hong, S.
Chem.-Asian J. 2015, 10, 878.
(Invited Article for 'The 10th Anniversary of the Asian Core Program (ACP)' themed collection)
68. HS-543 Induces Apoptosis of Imatinib-Resistant Chronic Myeloid Cells with T315I Mutation
Kim, S.-J.; Jung, K. H.; Yan, H. H., Son, M.-K.; Fang, Z.; Ryu, Y.-L.; Lee, H.; Kim, J.; Lee, S.; Hong, S.*; Hong, S.-S.*
ONCOTARGET 2015, 6, 1507-1518.
67. Anticancer Activity of HS-527, a Novel Inhibitor Targeting PI3-Kinase in Human Pancreatic Cancer Cells
Ryu, Y.-L.; Jung, K. H.; Son, M. K.; Yan, H. H.; Kim, S. J.; Shin, S.; Hong, S.*; Hong, S.-S.*
Cancer Lett. 2014, 353, 68.
66. HS-133, a Novel Fluorescent Phosphatidylinositol 3-Kinase Inhibitor as a Potential Imaging and Anticancer Agent for Targeted Therapy
Lee, J.-H.; Jung, K. H.; Lee, H.; Yun, S.-M., Son, M.-K.; Ahn, S.-H.; Lee, S.; Kim, D.; Hong, S.*; Hong, S.-S.*
ONCOTARGET 2014, 5, 10180.
65. Copper-Mediated Cross-Coupling Approach for the Synthesis of 3-Heteroaryl Quinolone and Related Analogues
Shin, S.; Kim, Y.; Kim, K.; Hong, S.
Org. Biomol. Chem. 2014, 12, 5719.
64. HS-104, a PI3K inhibitor, enhances anticancer efficacy of gemcitabine in pancreatic cancer
Jung, K. H.; Yan, H. H.; Fang, Z.; Son, M. K.; Lee, H.; Hong, S.; Hong, S.-S.
Int. J. Oncol. 2014, 45, 311-321.
